Objective:

To explore the problems with traditional postoperative drop regimens and the rationale for dropless cataract surgery (DCS) as a more effective alternative for improving patient outcomes.

Key Findings:

• Non-compliance with postoperative drops is common, particularly among elderly patients, leading to variability in treatment outcomes.
• Dropless cataract surgery can reduce costs and environmental impact associated with topical medications, as well as improve patient adherence.
• Intracameral antibiotics significantly reduce the risk of endophthalmitis without the need for postoperative drops, supported by large-scale studies.
• Subconjunctival corticosteroids are effective in controlling inflammation and preventing cystoid macular edema, with evidence suggesting they may outperform topical alternatives.

Interpretation:

Dropless cataract surgery improves patient care by standardizing treatment, enhancing adherence, and reducing the burden of postoperative care, ultimately leading to better surgical outcomes.

Limitations:

• Not all patients may be suitable for dropless surgery; careful patient selection is necessary to mitigate risks.
• Concerns about potential complications such as subconjunctival hemorrhage and steroid response remain, which could affect patient safety and satisfaction.

Conclusion:

Dropless cataract surgery aligns with evidence-based practices and patient-centered care, offering a promising alternative to traditional postoperative regimens that could significantly enhance patient outcomes.